In April, 1973, a decade-long study was begun on nuclear-powered pacemakers. The first 15 of these were designed by the Numec Corporation under a contract from the United States Atomic Energy Commission. Altogether 151 units powered by the isotope plutonium 238 were implanted in 131 patients; the pacemakers of 4 different manufacturers were used. The last nuclear pacemaker was implanted in January, 1983. The actuarial survival at 10 years was 92%, meeting the original performance goal of the Commission of 90%. Ninety pulse generators are still in service today; 25 patients have died and 36 pulse generators have been replaced with non-nuclear units. The most common indication for replacement was an inappropriate pacing mode. This high reliability and superior performance suggest that continued use of a radioisotopic power source is justified, particularly if combined with the electronic circuits of today's dual-chambered, multiprogrammable, and multifunctional pacemakers.